Arvee Laboratories (India) Ltd. (NSE:ARVEE)
India
· Delayed Price · Currency is INR 147.20
+6.63 (4.72%)
Mar 13, 2025, 3:25 PM IST
NSE:ARVEE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 381.81 | 303.45 | 613.47 | 399.65 | 473.75 | 454.19 | Upgrade
|
| Other Revenue | 0 | - | - | - | - | - | Upgrade
|
| Revenue | 381.81 | 303.45 | 613.47 | 399.65 | 473.75 | 454.19 | Upgrade
|
| Revenue Growth (YoY) | 34.53% | -50.54% | 53.50% | -15.64% | 4.31% | -17.27% | Upgrade
|
| Cost of Revenue | 203.91 | 147.02 | 394.48 | 224.4 | 295.02 | 291.7 | Upgrade
|
| Gross Profit | 177.89 | 156.43 | 218.99 | 175.25 | 178.74 | 162.49 | Upgrade
|
| Selling, General & Admin | 64.69 | 59.52 | 61.67 | 57.08 | 55.57 | 28.11 | Upgrade
|
| Other Operating Expenses | 71.95 | 67.54 | 84.51 | 65.02 | 62.48 | 74.17 | Upgrade
|
| Operating Expenses | 149.18 | 142.04 | 166.97 | 145.31 | 142.11 | 125.17 | Upgrade
|
| Operating Income | 28.71 | 14.39 | 52.02 | 29.94 | 36.62 | 37.32 | Upgrade
|
| Interest Expense | -1.68 | -1.88 | -2.86 | -3.15 | -4.92 | -8.91 | Upgrade
|
| Interest & Investment Income | 3.58 | 3.58 | 2.01 | 2.65 | 2.82 | 1.4 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.48 | 1.48 | 11.35 | 3.63 | -0.09 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.83 | 0.08 | -0.96 | -0.47 | -0.77 | -0.97 | Upgrade
|
| EBT Excluding Unusual Items | 32.92 | 17.65 | 61.56 | 32.6 | 33.67 | 28.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.64 | 0.64 | 0.08 | 1.24 | 2.95 | 2.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.01 | - | -0.21 | - | Upgrade
|
| Pretax Income | 33.56 | 18.3 | 61.65 | 34.49 | 36.41 | 30.91 | Upgrade
|
| Income Tax Expense | 11.62 | 7.78 | 20.46 | 8.75 | 9.64 | 7.92 | Upgrade
|
| Net Income | 21.94 | 10.52 | 41.19 | 25.74 | 26.77 | 22.99 | Upgrade
|
| Net Income to Common | 21.94 | 10.52 | 41.19 | 25.74 | 26.77 | 22.99 | Upgrade
|
| Net Income Growth | 132.17% | -74.46% | 60.04% | -3.87% | 16.46% | 1.60% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 9 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 9 | 11 | Upgrade
|
| Shares Change (YoY) | -0.03% | - | - | 29.28% | -22.65% | - | Upgrade
|
| EPS (Basic) | 1.99 | 0.95 | 3.74 | 2.34 | 3.14 | 2.09 | Upgrade
|
| EPS (Diluted) | 1.99 | 0.95 | 3.74 | 2.34 | 3.14 | 2.09 | Upgrade
|
| EPS Growth | 131.73% | -74.58% | 60.04% | -25.64% | 50.56% | 1.60% | Upgrade
|
| Free Cash Flow | - | 10.78 | 14.45 | -16.83 | -5.8 | 80.26 | Upgrade
|
| Free Cash Flow Per Share | - | 0.98 | 1.31 | -1.53 | -0.68 | 7.28 | Upgrade
|
| Gross Margin | 46.59% | 51.55% | 35.70% | 43.85% | 37.73% | 35.78% | Upgrade
|
| Operating Margin | 7.52% | 4.74% | 8.48% | 7.49% | 7.73% | 8.22% | Upgrade
|
| Profit Margin | 5.75% | 3.47% | 6.71% | 6.44% | 5.65% | 5.06% | Upgrade
|
| Free Cash Flow Margin | - | 3.55% | 2.36% | -4.21% | -1.22% | 17.67% | Upgrade
|
| EBITDA | 39.26 | 29.29 | 72.73 | 53.05 | 60.6 | 60.13 | Upgrade
|
| EBITDA Margin | 10.28% | 9.65% | 11.86% | 13.28% | 12.79% | 13.24% | Upgrade
|
| D&A For EBITDA | 10.54 | 14.9 | 20.71 | 23.12 | 23.98 | 22.81 | Upgrade
|
| EBIT | 28.71 | 14.39 | 52.02 | 29.94 | 36.62 | 37.32 | Upgrade
|
| EBIT Margin | 7.52% | 4.74% | 8.48% | 7.49% | 7.73% | 8.22% | Upgrade
|
| Effective Tax Rate | 34.62% | 42.51% | 33.19% | 25.38% | 26.48% | 25.61% | Upgrade
|
| Revenue as Reported | 388.96 | 309.85 | 626.99 | 407.9 | 479.6 | 457.65 | Upgrade
|
| Advertising Expenses | - | 0.23 | 0.31 | 0.17 | 0.14 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.